No photo of Kehinde Adekola

View Scopus Profile

Kehinde Adekola

  • 203 Citations
20122018
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Interested in stem cell/bone marrow transplantation for malignant and non-malignant disorders, and patient outcomes after these transplants. Interested in cancer health disparities specifically in hematologic disorders. Interested in global health with improvement in outcomes for hematologic and oncologic conditions in all regions.

Training Experience

2009Residency, SUNY/State University of New York Downstate Medical Center
2013Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)
2014Fellowship, University of Texas/MD Anderson Cancer Center

Education/Academic qualification

MS, Northwestern University

… → 2013

MBBS, University of Lagos

… → 2003

Keywords

  • Blood Cancer (leukemia and lymphomas)
  • Global Health
  • Health Disparities
  • Hematology
  • Oncology
  • Transplantation

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Cell Transplantation Medicine & Life Sciences
Transplants Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Metformin Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Glucose Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2018

Exploring the Potential of Dual Kinase JAK 1/2 Inhibitor Ruxolitinib (INC424) with Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis

Adekola, K.

Icahn School of Medicine at Mount Sinai, National Cancer Institute

7/1/14 → 12/31/18

Project: Research project

Janus Kinases
Primary Myelofibrosis
Cell Transplantation
INCB018424

Prot #NU MS16H07: Phase II Multicenter Study of Natalizumab Plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease

Adekola, K.

Icahn School of Medicine at Mount Sinai, Biogen Inc.

9/1/16 → 11/2/18

Project: Research project

Improving Outcomes of Older and Medically Infirm Patients with AML

Adekola, K. & Altman, J. K.

Fred Hutchinson Cancer Research Center, Patient-Centered Outcomes Research Institute

1/1/14 → 6/30/18

Project: Research project

Acute Myeloid Leukemia
Cell Transplantation
Comorbidity
Quality of Life
Selection Bias

Research Output 2012 2018

  • 203 Citations
  • 8 Article
  • 6 Review article
  • 1 Letter

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis

Wood, W. A., Brazauskas, R., Hu, Z. H., Abdel-Azim, H., Ahmed, I. A., Aljurf, M., Badawy, S., Beitinjaneh, A., George, B., Buchbinder, D., Cerny, J., Dedeken, L., Diaz, M. A., Freytes, C. O., Ganguly, S., Gergis, U., Almaguer, D. G., Gupta, A., Hale, G., Hashmi, S. K. & 30 othersInamoto, Y., Kamble, R. T., Adekola, K., Kindwall-Keller, T., Knight, J., Kumar, L., Kuwatsuka, Y., Law, J., Lazarus, H. M., LeMaistre, C., Olsson, R. F., Pulsipher, M. A., Savani, B. N., Schultz, K. R., Saad, A. A., Seftel, M., Seo, S., Shea, T. C., Steinberg, A., Sullivan, K., Szwajcer, D., Wirk, B., Yared, J., Yong, A., Dalal, J., Hahn, T., Khera, N., Bonfim, C., Atsuta, Y. & Saber, W., Sep 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 9, p. 1928-1935 8 p.

Research output: Contribution to journal › Article

Cell Transplantation
Human Development
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cell Survival
Transplants
1 Citations

Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

Buchbinder, D., Kelly, D. L., Duarte, R. F., Auletta, J. J., Bhatt, N., Byrne, M., Defilipp, Z., Gabriel, M., Mahindra, A., Norkin, M., Schoemans, H., Shah, A. J., Ahmed, I., Atsuta, Y., Basak, G. W., Beattie, S., Bhella, S., Bredeson, C., Bunin, N., Dalal, J. & 27 othersDaly, A., Gajewski, J., Gale, R. P., Galvin, J., Hamadani, M., Hayashi, R. J., Adekola, K., Law, J., Lee, C. J., Liesveld, J., Malone, A. K., Nagler, A., Naik, S., Nishihori, T., Parsons, S. K., Scherwath, A., Schofield, H. L., Soiffer, R., Szer, J., Twist, I., Warwick, A. B., Wirk, B. M., Yi, J., Battiwalla, M., Flowers, M. D. E., Savani, B. & Shaw, B. E., May 1 2018, In : Bone Marrow Transplantation. 53, 5, p. 535-555 21 p.

Research output: Contribution to journal › Review article

Cell Transplantation
Quality of Life
Transplants
Bone Marrow
Morbidity

Perspective: Sistas in science - Cracking the glass ceiling

Starlard-Davenport, A., Rich, A., Fasipe, T., Lance, E. I., Adekola, K., Forray, A., Steed, M., Fitzgerald, A., Walker, S. & Pace, B. S., Sep 1 2018, In : Ethnicity and Disease. 28, 4, p. 575-578 4 p.

Research output: Contribution to journal › Review article

Mentors
National Heart, Lung, and Blood Institute (U.S.)
Negotiating
Practice Guidelines
Research
2 Citations

Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia

Hamilton, B. K., Rybicki, L., Abounader, D., Adekola, K., Advani, A., Aldoss, I., Bachanova, V., Bashey, A., Brown, S., DeLima, M., Devine, S., Flowers, C. R., Ganguly, S., Jagasia, M., Kennedy, V. E., Kim, D. D. H., McGuirk, J., Pullarkat, V., Romee, R., Sandhu, K. & 8 othersSmith, M., Ueda, M., Viswabandya, A., Vu, K., Wall, S., Zeichner, S. B., Perales, M. A. & Majhail, N. S., Jul 1 2017, In : Biology of Blood and Marrow Transplantation. 23, 7, p. 1117-1121 5 p.

Research output: Contribution to journal › Article

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Cell Transplantation
Whole-Body Irradiation
Recurrence
Tissue Donors
4 Citations

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Kongtim, P., Adekola, K., Milton, D. R., Ramlal, R., Jimenez, A., Chen, J., Rondon, G., Ahmed, S., Kebriaei, P., Betul, O., Hosing, C. M., Popat, U., Khouri, I., Jabbour, E., Cortes, J. E., Kantarjian, H. M., Champlin, R. E. & Ciurea, S. O., Jul 1 2017, In : Leukemia. 31, 7, p. 1654-1657 4 p.

Research output: Contribution to journal › Letter

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Transplantation
Tissue Donors
Transplants